The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies.
- DOI
- 10.1016/j.leukres.2026.108356
- Published
- 2026 Oct 24
- Container
- Leukemia research
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.leukres.2026.108356,
title = {The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies.},
author = {Victoria Hincapie JS and Mondragon-Cardona A and Ochoa-Zárate L and Cabrera-Salcedo SC and Ríos-Serna LJ and Loukanov A and Garcia-Robledo JE and Toro-Pedroza A and Cañas CA and Arrieta López E and Baena JC},
year = {2026},
journal = {Leukemia research},
doi = {10.1016/j.leukres.2026.108356},
url = {https://doi.org/10.1016/j.leukres.2026.108356}
}RIS
TY - JOUR TI - The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies. AU - Victoria Hincapie JS AU - Mondragon-Cardona A AU - Ochoa-Zárate L AU - Cabrera-Salcedo SC AU - Ríos-Serna LJ AU - Loukanov A AU - Garcia-Robledo JE AU - Toro-Pedroza A AU - Cañas CA AU - Arrieta López E AU - Baena JC PY - 2026 JO - Leukemia research DO - 10.1016/j.leukres.2026.108356 UR - https://doi.org/10.1016/j.leukres.2026.108356 ER -
APA
JS, V. H., A, M., L, O., SC, C., LJ, R., A, L., JE, G., A, T., CA, C., E, A. L., & JC, B. (2026). The summa of ZUMA: Lessons from a decade of CD19-targeted CAR-T trials in B-cell malignancies.. Leukemia research. https://doi.org/10.1016/j.leukres.2026.108356
Source records
- pubmed · retrieved 2026-11-10T14:32:13.470Z